Women's Hospital School Of Medicine Zhejiang University
Clinical trials sponsored by Women's Hospital School Of Medicine Zhejiang University, explained in plain language.
-
Could a drug combo replace the knife for some endometrial cancers?
Disease control Not yet recruitingThis study tests two immunotherapy drugs (iparomlimab and tuvonralimab) in 30 women with a specific type of endometrial cancer that is mismatch repair-deficient. The goal is to see if the treatment can make the cancer disappear or shrink enough to avoid surgery. Participants must…
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New Immunotherapy-Chemo cocktail aims to boost cervical cancer survival
Disease control Not yet recruitingThis phase 2 trial tests whether adding the immunotherapy drug ivonescimab to chemotherapy before standard chemoradiation can improve outcomes for women with high-risk, locally advanced cervical cancer. About 42 participants will receive two cycles of the combination, then procee…
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New blood test could spot cervical cancer early in High-Risk women
Diagnosis Not yet recruitingThis study aims to develop a blood test that can accurately detect serious cervical lesions in women infected with HPV16 or HPV18, the high-risk types linked to cervical cancer. Researchers will collect blood samples and medical data from about 1,465 women across three hospitals …
Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC